$MLEC Cashflow Statement | Understand Stock

$MLEC

$1.51 +$0.04 (2.72%) Close

$MLEC Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statement of Cash Flows

In millions of USD, except per-share amounts

	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023
OPERATING ACTIVITIES
(Loss) / profit for the year
Adjustments to reconcile (loss) / profit to net cash flows
Income tax
Depreciation and amortization
Depreciation of property, plant and equipment
Amortization of intangible assets
Depreciation of fixed assets
Depreciation of right-of-use assets
Depreciation of leased assets
Gain from a bargain purchase
Remeasurement of previously held interest
Share-based incentive and stock options
Change in fair value of Simply Agreement for Future Equity (“SAFE”)
Share based payment cost of listing shares (non-cash item)
Financial income / (expenses)
Share of profit or loss of joint ventures and associates
Provisions for contingencies
Allowance for impairment of trade debtors
Allowance for obsolescence
Initial recognition and changes in the fair value of biological assets
Changes in the net realizable value of agricultural products after harvest
Financial results
Gain on sale of equipment and intangible assets
Working capital adjustments
Trade receivables
Other receivables
Prepayments
Inventories and biological assets
Accounts payable
Other liabilities
Trade and other payables
Employee benefits and social security
Government grants
Income tax paid
Deferred revenue and advances from customers
Net cash flows generated by / (used in) operating activities
INVESTMENT ACTIVITIES
Proceeds from sale of property, plant and equipment
Investment in joint ventures and associates
Net cash received from business combination
Loss of controlling interest
Proceeds from financial assets
Investment in financial assets
Purchase of property, plant and equipment
Capitalized development expenditures
Purchase of intangible assets
Short term investment subscriptions
Short-term investments withdrawals
Net cash flows used in investing activities
FINANCING ACTIVITIES
Proceeds from issuance of share capital to UGVL and Theo (Backstop)
Proceeds from issuance of share capital to SPAC public holders (Trust)
Proceeds from issuance of convertible notes
Proceeds from financial debts
Proceeds from borrowings
Repayment of borrowings and financed payments
Interest payments
Proceeds from issue of shares
Leased assets payments
Deferred payment for acquisition of ValoraSoy
Settlement with shareholders (addition of treasury shares) (see note 15)
Cash dividend distributed by non-controlling interest
Other financial payments
Purchase of own shares
Net cash flows (used in) / generated by financing activities
Net increase / (decrease) in cash and cash equivalents
Inflation effects on cash and cash equivalents
Cash and cash equivalents as of beginning of the year
Effect of exchange rate changes and inflation on cash and equivalents
Effect of exchange rate changes on cash and equivalents
Cash and cash equivalents as of the end of the year
Issue of share capital and Share premium of New Shareholders through other non-current receivables
Relief of SAFE financial liabilities through the issue of Share Capital and Share Premium
Capitalization of transaction expenses through Accounts payables
Net liabilities acquired through issuance of share capital
Acquisition of Business Combination trough deferred payment
Acquisition of Business Combination trough deferred payment in kind
Increase in Right-of-use asset recognition through an increase in Lease liabilities
Increase in Intangible asset recognition through Accounts payables

Comments